组织切片市场规模、份额和成长分析：按产品、技术、应用、最终用户和地区划分 - 产业预测，2024-2031 年

2022年组织切片市场规模预计为16.8亿美元，从2023年的18.6亿美元成长到2031年的42.3亿美元，预计复合年增长率为10.80%。

组织切片市场在医疗保健和生命科学领域占据重要地位，为研究、诊断和治疗提供重要支持。本概述提供了对塑造市场的主要趋势、市场成长驱动因素和挑战的全面见解。组织切片是指将组织样本精确分割成薄片以供显微镜检查，在组织病理学、分子生物学、药物发现和临床诊断等应用中发挥基础作用。市场扩张的主要驱动力是癌症和神经系统疾病等慢性疾病盛行率的上升，病理学家和研究人员对探索疾病机制、评估治疗效果和科学研究的需求越来越大。 。技术进步，特别是自动化高通量系统，透过提高效率、准确性和可重复性以及最大限度地减少诊断和研究错误，改变了组织切片的实用性。此外，对个人化医疗和精确诊断的日益重视进一步强调了先进组织切片技术提供的详细组织分析的重要性。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 监管环境
• 关键成功因素
• 价值链分析
• 市场吸引力指数
• 竞争程度
• 主要投资机会
• 生态系绘图

组织切片市场：副产品

• 市场概况
• 装置
  • 旋转式切片机
  • 滑动切片机
  • 超薄切片机
  • 低温恒温器机
  • 其他的
• 配件/消耗品
• 服务

组织切片市场：依技术分类

• 市场概况
• 自动的
• 半自动
• 手动的

组织切片製备市场：依应用分类

• 市场概况
• 诊断
• 研究

组织切片市场：依最终使用者划分

• 市场概况
• 医院
• 诊所
• 诊断实验室
• 研究中心

组织切片製备市场规模：依地区划分

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Leica Biosystems（USA）
• Thermo Fisher Scientific Inc.（USA）
• Sakura Finetek USA, Inc.（USA）
• Danaher Corporation（USA）
• Agilent Technologies, Inc.（USA）
• Merck KGaA（Germany）
• Roche Diagnostics（Switzerland）
• CellPath Ltd（UK）
• Gilson Incorporated（USA）
• RMC Boeckeler（USA）
• Slee Medical GmbH（Germany）
• MEDITE GmbH（Germany）
• Jinhua YIDI Medical Appliance Co., Ltd.（China）
• Diapath SpA（Italy）
• Hacker Instruments & Industries Inc.（USA）
• Bright Instrument Company Ltd（UK）
• Boeckel+Co（GmbH+Co）KG（Germany）
• Jinhua Yidi Medical Appliance Co., Ltd.（China）
• MICROS Produktions-und Handelsgesellschaft mbH（Austria）
• Nanolytik GmbH（Germany）
• Microservice Srl（Italy）
• SLEE medical GmbH（Germany）
• Screen Holdings Co., Ltd.（Japan）
• REMI Group（India）
• Marienfeld Superior（Germany）

Tissue Sectioning Market size was valued at USD 1.68 billion in 2022 and is poised to grow from USD 1.86 billion in 2023 to USD 4.23 billion by 2031, growing at a CAGR of 10.80% during the forecast period (2024-2031).

The Tissue Sectioning Market holds significant importance within healthcare and life sciences, crucially supporting research, diagnostics, and medical treatments. This overview offers a comprehensive insight into the key trends, drivers of growth, and challenges shaping the market. Tissue sectioning entails the precise division of tissue samples into thin slices for microscopic examination, playing a fundamental role in applications spanning histopathology, molecular biology, drug discovery, and clinical diagnostics. A major catalyst for market expansion is the rising incidence of chronic diseases like cancer and neurological disorders, driving demand among pathologists and researchers who depend on tissue sectioning to explore disease mechanisms, assess treatment efficacy, and advance scientific understanding. Technological advancements, particularly automated and high-throughput systems, have transformed tissue sectioning practices by enhancing efficiency, accuracy, and reproducibility, thereby minimizing diagnostic and research errors. Furthermore, the increasing emphasis on personalized medicine and precision diagnostics further underscores the criticality of detailed tissue analysis provided by advanced tissue sectioning techniques, essential for tailored patient care strategies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Tissue Sectioning Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Tissue Sectioning Market Segmental Analysis

The Tissue Sectioning Market is segmented on the basis of product, technology, application, end-use and region. By product, the market is segmented into Instruments (Rotary Microtome, Sliding Microtome, Ultramicrotome, Cryostat microtome, others), Accessories & Consumables, Services. Based on technology, the market is segmented into automatic, semiautomatic, and manual. Based on application, the market is segmented into diagnosis and research. Based on end-use, the market is segmented into hospitals, clinics, diagnostic laboratories, and research centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Tissue Sectioning Market

The increasing incidence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders has significantly propelled the tissue sectioning market forward. Tissue sectioning plays a critical role in pathology and research by facilitating the diagnosis and comprehension of these ailments. With an aging population and a growing prevalence of chronic diseases, there has been a heightened demand for tissue sectioning equipment and services. Concurrently, technological advancements in tissue sectioning equipment and techniques have been pivotal. Enhanced automation, precision, and the development of advanced staining methods have markedly improved the efficiency and accuracy of tissue sectioning. These innovations not only bolster research and diagnostic capabilities but also streamline the procedural time and labor involved in tissue sectioning.

Restraints in the Tissue Sectioning Market

High equipment costs associated with tissue sectioning, particularly advanced automated systems, pose a significant barrier for smaller laboratories, clinics, and research institutions with limited budgets, restraining the adoption of this technology in resource-constrained settings. Additionally, stringent regulatory requirements for clinical diagnostics impose substantial time and financial burdens on manufacturers and laboratories, aiming to ensure accuracy and patient safety. These regulations, coupled with potential delays in approvals or changes, further hinder the growth of the tissue sectioning market by complicating product launches and limiting market access.

Market Trends of the Tissue Sectioning Market

Automation and digitization are transforming the tissue sectioning landscape, marking a significant trend in the market. This evolution is characterized by the widespread adoption of automated equipment like microtomes and cryostats, aimed at enhancing the precision and efficiency of tissue sectioning while minimizing the risk of cross-contamination. Moreover, the shift towards digitizing tissue sections facilitates easier storage, analysis, and sharing of samples through digital pathology systems and advanced image analysis software. In parallel, tissue sectioning's pivotal role spans across diverse domains such as medical research, pathology, and clinical diagnostics, responding to escalating demands in cancer research, neuroscience, drug development, and disease diagnosis. This trend is driven by ongoing advancements in genomics and proteomics, underscoring tissue sectioning's indispensable contribution to research and diagnostic applications, poised for continued growth in the foreseeable future.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Regulatory Landscape
• Key Success Factors
• Value Chain Analysis
• Market Attractiveness Index
• Degree of Competition
• Top Investment Pockets
• Ecosystem Mapping

Tissue Sectioning Market by Product

• Market Overview
• Instruments
  • Rotary Microtome
  • Sliding Microtome
  • Ultramicrotome
  • Cryostat microtome
  • Others
• Accessories & Consumables
• Services

Tissue Sectioning Market by Technology

• Market Overview
• Automatic
• Semiautomatic
• Manual

Tissue Sectioning Market by Application

• Market Overview
• Diagnosis
• Research

Tissue Sectioning Market by End User

• Market Overview
• Hospitals
• Clinics
• Diagnostic Laboratories
• Research Center

Gasoline Gensets Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Leica Biosystems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sakura Finetek USA, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CellPath Ltd (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilson Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RMC Boeckeler (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Slee Medical GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MEDITE GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jinhua YIDI Medical Appliance Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diapath S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hacker Instruments & Industries Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bright Instrument Company Ltd (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boeckel + Co (GmbH + Co) KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jinhua Yidi Medical Appliance Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MICROS Produktions- und Handelsgesellschaft m.b.H (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nanolytik GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microservice S.r.l. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SLEE medical GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Screen Holdings Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• REMI Group (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Marienfeld Superior (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments